1st Quarter - Termination
W STRATEGIES, LLC for HORIZON PHARMA USA, INC.
Firm
Client
Income
$20,000
Expenses
—
Terminated
Feb 28, 2017
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to orphan drugs and the value of innovative medicines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.